CollPlant Biotechnologies Ltd. (CLGN)
CLGN Stock Price Chart
Explore CollPlant Biotechnologies Ltd. interactive price chart. Choose custom timeframes to analyze CLGN price movements and trends.
CLGN Company Profile
Discover essential business fundamentals and corporate details for CollPlant Biotechnologies Ltd. (CLGN) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Biotechnology
IPO Date
31 Jan 2018
Employees
57.00
Website
https://www.collplant.comCEO
Yehiel Tal
Description
CollPlant Biotechnologies Ltd. is a regenerative and aesthetic medicine enterprise operating across the United States, Canada, and Europe. The company primarily engages in the three-dimensional (3D) bioprinting of tissues and organs, alongside developing solutions for medical aesthetics. All of CollPlant's offerings are underpinned by its proprietary plant-based genetic engineering technology, which facilitates the production of recombinant type I human collagen. Its diverse product portfolio encompasses BioInks engineered for 3D tissue and organ fabrication; dermal and soft tissue fillers designed to diminish wrinkles; and innovative breast implants, both 3D bioprinted and injectable, aimed at promoting breast tissue regeneration. CollPlant also provides a 3D bioprinted regenerative soft tissue matrix. Specialized products include VergenixSTR, a soft tissue repair matrix targeting tendinopathy, and VergenixFG, an advanced wound care treatment for deep surgical incisions and persistent wounds such as diabetic, venous, and pressure ulcers, burns, and bedsores. The company maintains strategic collaboration agreements with numerous partners, including 3D Systems Corporation, CellInk (a BICO Group company), the Advanced Regenerative Manufacturing Institute, the RegenMed Development Organization, Israel's Technion Institute of Technology, AbbVie, and STEMCELL. Established in Rehovot, Israel, in 2004, the company was formerly known as CollPlant Holdings Ltd. before adopting its current name in June 2019.
CLGN Financial Timeline
Browse a chronological timeline of CollPlant Biotechnologies Ltd. corporate events including earnings releases, dividend announcements, and stock splits.
Upcoming earnings on 20 Aug 2026
EPS estimate is -$0.24, while revenue estimate is $480.00k.
Earnings released on 29 May 2026
EPS came in at -$0.23 surpassing the estimated -$0.24 by +3.12%, while revenue for the quarter reached $73.00k , missing expectations by -84.13%.
Earnings released on 26 Mar 2026
EPS came in at -$0.67 falling short of the estimated -$0.30 by -125.06%, while revenue for the quarter reached $60.00k , missing expectations by -97.11%.
Earnings released on 26 Nov 2025
EPS came in at -$0.27 falling short of the estimated $0.38 by -171.05%, while revenue for the quarter reached $77.00k , missing expectations by -98.86%.
Earnings released on 20 Aug 2025
EPS came in at -$0.28 falling short of the estimated -$0.10 by -180.00%, while revenue for the quarter reached $179.00k , missing expectations by -98.92%.
Earnings released on 28 May 2025
EPS came in at -$0.13 surpassing the estimated -$0.37 by +64.86%, while revenue for the quarter reached $2.06m , missing expectations by -76.94%.
Earnings released on 26 Mar 2025
EPS came in at -$0.34 surpassing the estimated -$0.42 by +19.05%, while revenue for the quarter reached $164.00k , beating expectations by +64.00%.
Earnings released on 27 Nov 2024
EPS came in at -$0.38 falling short of the estimated -$0.28 by -35.71%, while revenue for the quarter reached $4.00k , missing expectations by -98.90%.
Earnings released on 20 Aug 2024
EPS came in at -$0.37 falling short of the estimated -$0.35 by -5.71%, while revenue for the quarter reached $249.00k , missing expectations by -40.71%.
Earnings released on 29 May 2024
EPS came in at -$0.37 falling short of the estimated -$0.35 by -5.71%, while revenue for the quarter reached $98.00k , missing expectations by -84.74%.
Earnings released on 4 Apr 2024
EPS came in at -$0.42 falling short of the estimated $0.24 by -275.00%, while revenue for the quarter reached $309.00k , missing expectations by -96.39%.
Earnings released on 29 Nov 2023
EPS came in at -$0.38 falling short of the estimated -$0.13 by -192.31%, while revenue for the quarter reached $43.00k , missing expectations by -99.01%.
Earnings released on 24 Aug 2023
EPS came in at $0.49 surpassing the estimated $0.02 by +3.17k%, while revenue for the quarter reached $10.18m , beating expectations by +5.26k%.
Earnings released on 24 May 2023
EPS came in at -$0.33 falling short of the estimated -$0.29 by -13.79%, while revenue for the quarter reached $433.00k , beating expectations by +80.42%.
Earnings released on 29 Mar 2023
EPS came in at -$0.39 falling short of the estimated -$0.21 by -85.71%, while revenue for the quarter reached $58.00k , beating expectations by +16.00%.
Earnings released on 1 Dec 2022
EPS came in at -$0.40 falling short of the estimated -$0.31 by -29.03%, while revenue for the quarter reached $109.00k , missing expectations by -96.48%.
Earnings released on 25 Aug 2022
EPS came in at -$0.39 falling short of the estimated -$0.08 by -387.50%, while revenue for the quarter reached $66.00k , missing expectations by -97.69%.
Earnings released on 26 May 2022
EPS came in at -$0.36 falling short of the estimated -$0.14 by -157.14%, while revenue for the quarter reached $66.00k , missing expectations by -97.59%.
Earnings released on 24 Mar 2022
EPS came in at -$0.30 falling short of the estimated -$0.26 by -15.38%, while revenue for the quarter reached $310.00k , missing expectations by -8.28%.
Earnings released on 18 Nov 2021
EPS came in at -$0.29 falling short of the estimated -$0.28 by -3.57%, while revenue for the quarter reached $140.00k , missing expectations by -99.34%.
Earnings released on 19 Aug 2021
EPS came in at -$0.30 falling short of the estimated -$0.10 by -200.00%, while revenue for the quarter reached $691.00k .
CLGN Stock Performance
Access detailed CLGN performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.
